Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computed Quantitative Planar Imaging for Targeted Alpha Therapy: Model-Based Sparse Reconstruction Validated With a Novel <sup>225</sup>Ac Epoxy Phantom.

IEEE transactions on medical imaging·2026
Same author

Tumor Microenvironment: Insights from Multiparametric MRI in Pancreatic Ductal Adenocarcinoma.

Cancers·2026
Same author

Differential Clearance of [<sup>177</sup>Lu]Lu-PSMA-617 from Metastatic Prostate Cancer Lesions and Normal Tissues creates a Window for Safe Application of DNA Repair Inhibitors.

medRxiv : the preprint server for health sciences·2025
Same author

Monte Carlo-based subcellular comparison of electron energy deposition by <sup>177</sup>Lu and <sup>161</sup> Tb: implications for targeted radiopharmaceutical therapy.

EJNMMI physics·2025
Same author

Apparent Diffusion Coefficient Magnetic Resonance Imaging as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in Human Papillomavirus-Associated Oropharyngeal Cancer.

International journal of radiation oncology, biology, physics·2025
Same author

Dual-[<sup>18</sup>FMISO + <sup>18</sup>FLT] PET/CT and MRI imaging in glioblastoma.

Medical physics·2025
Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Bone marrow dosimetry using 124I-PET.

Jazmin Schwartz1, John L Humm, Chaitanya R Divgi

  • 1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. schwarj1@mskcc.org

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|March 15, 2012
PubMed
Summary
This summary is machine-generated.

Directly measuring red marrow absorbed radiation dose using PET/CT is crucial for radioimmunotherapy. This study found that simple plasma activity concentration estimates are inaccurate, highlighting the need for individualized, image-based dosimetry to optimize treatment.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Related Experiment Videos

Last Updated: May 24, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

Area of Science:

  • Nuclear Medicine
  • Radiopharmaceutical Therapy
  • Medical Imaging

Background:

  • Bone marrow dose is a critical factor limiting radioimmunotherapy efficacy.
  • Accurate dosimetry is essential for optimizing therapeutic radiolabeled antibody delivery.
  • Previous methods relied on plasma activity concentration, which may not reflect red marrow dose.

Purpose of the Study:

  • To directly estimate red marrow absorbed radiation dose using PET/CT.
  • To compare image-based dose estimates with plasma activity concentration-based estimates.
  • To evaluate the accuracy of different dosimetry methods for (124)I-labeled antibodies.

Main Methods:

  • Utilized PET/CT imaging in patients receiving (124)I-cG250 or (124)I-huA33 monoclonal antibodies.
  • Quantified red marrow activity concentration in lumbar vertebrae and plasma activity concentration from blood samples.
  • Calculated red marrow-to-plasma activity concentration ratio (RMPR) and estimated self-dose using image-based, plasma-based, and hybrid methods.

Main Results:

  • Red marrow-to-plasma activity concentration ratio (RMPR) increased over time for both antibody groups.
  • Plasma-based dose estimates showed significant discrepancies compared to image-based values (average 11-47%).
  • A hybrid method combining RMPR(t) and plasma concentration more closely matched image-based dose estimates.

Conclusions:

  • Time-independent proportionality between red marrow and plasma activity is an oversimplification.
  • Individualized, image-based dosimetry is likely necessary for optimal radioimmunotherapy.
  • Accurate dosimetry may permit increased administered activity, potentially enhancing tumor dose without compromising bone marrow.